Table 2. Associations of LINC00472 with Breast Cancer Survival in Turin Study.
Unadjusted Cox Regression Model | ||||||
---|---|---|---|---|---|---|
LincRNA | HR1 for relapse | 95% CI2 | p value | HR for death | 95% CI | p value |
Low | 1 | 1 | ||||
Mid | 0.55 | 0.34–0.88 | 0.012 | 0.47 | 0.27–0.81 | 0.006 |
High | 0.28 | 0.14–0.58 | < 0.001 | 0.34 | 0.16–0.72 | 0.005 |
Continuous | 0.54 | 0.39–0.74 | <0.001 | 0.55 | 0.38–0.80 | 0.002 |
Adjusted Cox Regression Model* | ||||||
LincRNA | HR for relapse | 95% CI | p value | HR for death | 95% CI | p value |
Low | 1 | 1 | ||||
Mid | 0.82 | 0.48–1.39 | 0.45 | 0.62 | 0.33–1.16 | 0.134 |
High | 0.44 | 0.20–0.97 | 0.043 | 0.51 | 0.21–1.22 | 0.129 |
Continuous | 0.70 | 0.48–1.00 | 0.050 | 0.69 | 0.45–1.07 | 0.098 |
Adjusted for age, stage, grade, histology, ER, PR, nodal status and adjuvant treatment.
HR: Hazards Ratio
CI: Confidence Interval